ã¡ãã£ã¢èšäº
å€ç°ãŠã€ã«ã¹ã«ã¯ã¯ãã³ã¯å¹ãã®ïŒ
ããºãææ°ããŒã¯ 677
twitterã³ã¡ã³ã 147ä»¶äž 1ïœ100件
âŠãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ã®å¹ææ¯èŒè¡š
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã105人åæ
1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«
暪æµåžç«å€§åŠé¢é£ãµã€ã
è«æãµã€ã
1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«
暪æµåžç«å€§åŠé¢é£ãµã€ã
è«æãµã€ã
ã2021幎5æ12æ¥ããã¯ã¯ãã³ã2åæ¥çš®ããå»çåŸäºè
105人ã察象ã«ãè¡æ¶²ãæ¡åããŠãå€ç°ãŠã€ã«ã¹ãžã®ææãé²ãåãã®ãããäžåæäœããæäœã®çæé床ã¯æãã
ã暪æµåžç«å€§åŠå»åŠéšã®å±±äžç«¹æ¥ææããå人差ããããäœå æ®æ調æ»ãClinical TrialïŒèšåºè©ŠéšïŒãç¡ã
ã暪æµåžç«å€§åŠå»åŠéšã®å±±äžç«¹æ¥ææããå人差ããããäœå æ®æ調æ»ãClinical TrialïŒèšåºè©ŠéšïŒãç¡ã
ããã
ãã¯ããããããŸãâ
NHKã®ãã¥ãŒã¹ã§ã¯ãã¡ãã§ãðð»ââïž
(åŒçš)
NHKã®ãã¥ãŒã¹ã§ã¯ãã¡ãã§ãðð»ââïž
(åŒçš)
å¹æããã¿ããã£ããã
ããŒãã¯NHKã ãããã
ããŒãã¯NHKã ãããã
ãããããããªæãã§ã®ããŸãªæ¥æ¬ããæ±äº¬äºèŒªéå¬ãŸã§ã«2åç®ã®æåãªãã絶察ç¡çã ãªãšæããŸããŠãïŸïŸïŸïŸ
ãšãã£ãŠã調ã¹ãã°ã£ããªã®ã§ããã©ãïŒç¬
ãããªã® æ¥æ¬ æåçðã§åºãŠããŸãããã
ãšãã£ãŠã調ã¹ãã°ã£ããªã®ã§ããã©ãïŒç¬
ãããªã® æ¥æ¬ æåçðã§åºãŠããŸãããã
ïŒæšªæµåžç«å€§åŠã®ç 究ã°ã«ãŒãã¯ãåœå
ã§æ¥çš®ãããŠããã¯ã¯ãã³ïŒãã¡ã€ã¶ãŒè£œïŒãå€ç°ãŠã€ã«ã¹ã«ã©ããŸã§æå¹ãªã®ãã調ã¹ãç 究ãå®æœããŸãã
ïŒããšã3æãã4æã«ãããŠã¯ã¯ãã³ã2åæ¥çš®ããå»çåŸäºè 105人ã察象ã«ãè¡æ¶²ãæ¡åããŠãå€ç°ãŠã€ã«ã¹ãžã®ææãé²ãâŠ
ïŒããšã3æãã4æã«ãããŠã¯ã¯ãã³ã2åæ¥çš®ããå»çåŸäºè 105人ã察象ã«ãè¡æ¶²ãæ¡åããŠãå€ç°ãŠã€ã«ã¹ãžã®ææãé²ãâŠ
ãã®ããŒã¿ã¯å®å¿ææã ãã
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒãã¯ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ãå€ç°ãŠã€ã«ã¹ã«ã©ããŸã§æå¹ãªã®ãã調ã¹ç 究å®æœ
åæã®çµæ89ïŒ ã®äººã¯7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ ã§ããéã®äžåæäœãäœå ã«äœãããŠãããšå ±ãã
åæã®çµæ89ïŒ ã®äººã¯7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ ã§ããéã®äžåæäœãäœå ã«äœãããŠãããšå ±ãã
â ããã¯ããŠã³äžŠã¿ã®è¶
ç·æ¥äºæ
宣èš
ð
ðã¯ã¯ãã³æ¥çš®ã§éå£å ç«ãŸã§
â¡è²¡æ¿åºåã«ããçæ°Žã®è£åæäœ100å
ð
ð°åœåµçºè¡
â¢äºèŒªæ¥ç§ã«å延æ
å€å£ãå¬å£åææéå¬ðââïžð
ã§ããªããªãäžæ¢
åœãå®ãð
çµæžãåãð°
ãã³ãã«ã®å ã«å ãð
ð
ðã¯ã¯ãã³æ¥çš®ã§éå£å ç«ãŸã§
â¡è²¡æ¿åºåã«ããçæ°Žã®è£åæäœ100å
ð
ð°åœåµçºè¡
â¢äºèŒªæ¥ç§ã«å延æ
å€å£ãå¬å£åææéå¬ðââïžð
ã§ããªããªãäžæ¢
åœãå®ãð
çµæžãåãð°
ãã³ãã«ã®å ã«å ãð
ããã£ãšæžãããŠããã©ãããæ±äº¬æ ªãªã®ã§ã¯âŠïŒ â "æ±äº¬ãªã©ã§èŠã€ãã£ãE484Kãšããå€ç°ã®ããç±æ¥äžææ ª"
ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³æ¥çš®2ååŸãªãããªãã®å¹æããã£ããšãããã¥ãŒã¹ã¯ãããŸãã
暪æµåžç«å€§ã®ã¯ã¯ãã³ã®å¹æã§ãäœæ
æŠæŒ¢æ ªã§ã¯ãªãåŸæ¥æ ªãšåŒã¶ãšè©±é¡ã«ãªã£ãŠããããã©
ãã¹ã³ãã®åã«æšªåžã"åŸæ¥æ ª"ãšããèšãæ¹ãããŠããŠ
è«æã§ã¯prototype virus (D614G) ã ãããæŠæŒ¢æ ªã§ãªããã®åŸæµè¡ããæ ª
ãã¹ã³ãã®åã«æšªåžã"åŸæ¥æ ª"ãšããèšãæ¹ãããŠããŠ
è«æã§ã¯prototype virus (D614G) ã ãããæŠæŒ¢æ ªã§ãªããã®åŸæµè¡ããæ ª
ã»ãŒã
åæã®çµæãå
šäœã®89ïŒ
ã®äººã¯ã€ã®ãªã¹ãåã¢ããªã«ãããã«ãã©ãžã«ãªã©ã§åãããŠåãããŠ7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ
ã§ããéã®äžåæäœããäœå
ã«äœãããŠããããšãããããŸããã
暪æµåžç«å€§åŠç 究ã°ã«ãŒã
ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ã®å€ç°æ ªã«å¯Ÿããæå¹æ§
ã¯ã¯ãã³2åæ¥çš®å®äºå»çåŸäºè 105人察象
è¡æ¶²æ¡åã«ãããå€ç°æ ªãžã®ææãé²ãåãã®ãããäžåæäœãã®çšåºŠã調æ»
ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ã®å€ç°æ ªã«å¯Ÿããæå¹æ§
ã¯ã¯ãã³2åæ¥çš®å®äºå»çåŸäºè 105人察象
è¡æ¶²æ¡åã«ãããå€ç°æ ªãžã®ææãé²ãåãã®ãããäžåæäœãã®çšåºŠã調æ»
çåã¯ããã®ã§ãããäžå¿
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ ã§ããæäœãäœå ã«äœãããŠãããšããç 究çµæããŸãšããŸããã
å€ç°æ ªã«ã¯ã¯ãã³ã¯å¹ãã®ïŒ
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ ã§ããæäœãäœå ã«äœãããŠãããšããç 究çµæããŸãšããŸããã
å€ç°æ ªã«ã¯ã¯ãã³ã¯å¹ãã®ïŒ
æšæ¥ã®å ±éã§ããããåãã§ããïŒ
ãã¡ã€ã¶ãŒè£œã®ã¯ã¯ãã³ããå€ç°æ ªã«å¯ŸããŠãå¹æãããããšãã暪æµåžç«å€§åŠãçºè¡šããŠããŸãã
ãã¡ã€ã¶ãŒè£œã®ã¯ã¯ãã³ããå€ç°æ ªã«å¯ŸããŠãå¹æãããããšãã暪æµåžç«å€§åŠãçºè¡šããŠããŸãã
ã¡ãããšç 究ããŠãã人ãããŠãããã£ãã
å©æš©ãæ¿å±ã§ã¯ãªããããããç§åŠçç¥èŠã«åºã¥ããŠæ¿çãåããŠã»ããããä»ã®æ¿æš©ã«ã¯æåŸ ã§ãããã«ãªãã
å©æš©ãæ¿å±ã§ã¯ãªããããããç§åŠçç¥èŠã«åºã¥ããŠæ¿çãåããŠã»ããããä»ã®æ¿æš©ã«ã¯æåŸ ã§ãããã«ãªãã
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ
ã§ããæäœãäœå
ã«äœãããŠããã
ã€ããã倧äžå€«ã
ã ã®ç 究ã°ã«ãŒããå
¬è¡šããããŒã¿ãåºã«ã1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«ããšã®äžèŠ§è¡šãæ²èŒããŠããŸãã
ïŒåç®ã§40%以äžã®å¹æããåŸãããªãã®ã«ãïŒåç®ã§ãããªã90%ãè¶ ããã®ã¯ãæããã«äœããã®ãã¹ããããšèããããŸãã
ïŒåç®ã§40%以äžã®å¹æããåŸãããªãã®ã«ãïŒåç®ã§ãããªã90%ãè¶ ããã®ã¯ãæããã«äœããã®ãã¹ããããšèããããŸãã
çŸåšæ¥æ¬ã§æ¥çš®ãããŠããã¯ã¯ãã³ã¯ã
2åæ¥çš®ããã°ã
ããã9å²ã®äººã«
å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ ã§ãã
ãäžåæäœããäœå ã«äœãããŠãããšããç 究çµæã
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒãã
ã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠ
åæããå 容ããŸãšãããšã®ããš
2åæ¥çš®ããã°ã
ããã9å²ã®äººã«
å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ ã§ãã
ãäžåæäœããäœå ã«äœãããŠãããšããç 究çµæã
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒãã
ã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠ
åæããå 容ããŸãšãããšã®ããš
å¹æãæåŸ
ã§ããéã®äžåæäœãåºæ¥ã確çã§ãã£ãŠãå¥ã«ïŒïŒïŒ
ã®ç¢ºçã§ææããªãã£ãŠè©±ã§ã¯ãªãã»ã»ããªãã®æç« ã ãšã
ãŸãã§ãæäœã¯ã»ãŒç¢ºå®ã«åºæ¥ãŠå¹æèªäœã¯ãããã ãçïŒåæãŠã°ã³ãããåãŸã£ãŠãããšä¿¡ããŠ(*ÂŽ-`)
ãŸãã§ãæäœã¯ã»ãŒç¢ºå®ã«åºæ¥ãŠå¹æèªäœã¯ãããã ãçïŒåæãŠã°ã³ãããåãŸã£ãŠãããšä¿¡ããŠ(*ÂŽ-`)
ãŠã€ã«ã¹ã«å¯Ÿããäžåæäœãªã®ã
ãããšã
ã¯ã¯ãã³ã«å¯Ÿããäžåæäœãªã®ã
ãããšã
ã¯ã¯ãã³ã«å¯Ÿããäžåæäœãªã®ã
2åæãŠã°å®å¿ã§ããã®ãð
ââ ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³ãåçš®å€ç°æ ªã«å¯ŸããŠãå¹æçãšããã®ã¯æå ±ã ãããå¹æãæåŸ
ã§ããéã®æäœãããå²åãããææããªãå²åããšã©ãããé¢ä¿ã§ãããã¯æ°ã«ãªãã
ãã¡ã€ã¶ãŒã¯ã¯ãã³æ¥çš®2åç®10æ¥ä»¥éè¡æ¶²äžã®äžåæäœãã¹ãŽã€!ðåãäœçšæ©åºã®ã¢ãã«ã瀟(mRNAã¯ã¯ãã³)ãåççµæåºãã°ãããðé¡èãªå·®ãåºããšã倧èŠæš¡æ¥çš®äŒå Žã¯éæ£åã®æžå¿µããã®ã§ã¯ð±
å€ç°æ ªã«å¹ãã¿ããã§ãããã¡ãã£ãšå®å¿ããŸããã
幎å ã«æ¥çš®ã§ãããããªïŒ
幎å ã«æ¥çš®ã§ãããããªïŒ
å
šäœ89ïŒ
ã®äººã¯ã€ã®ãªã¹ãåã¢ããªã«ããã©ãžã«ãªã©ã§åãããŠ7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ
ã§ããéã®äžåæäœããäœå
ã«äœãããŠããããšãããããŸãããå°ãåžæãåºãŠããŸãããã
ã¯ã¯ãã³ã¯ææãã®ãã®ã¯é²ããªããããã¯åŸæ¥çš®ãå€ç°çš®ãåãããã ä»®ã«ææããŠãã¯ã¯ãã³ãéçåãé²ãã§ãããã°å»çè³æºã¯æ¯æžãããæåœãŠã§ããã«äº¡ããªãåœããã®ä»ç
ã§äº¡ããªãåœãæãããå¿
èŠéã®ïŒåã確å®ã«æã€ããšããå€ç°çš®ã«å¯Ÿæããæ¹çã¯ãªãã ãã
ïŒåæã£ãã ãã§ããªãå®å¿ããŠããŸãããªããªãæå·®åºå€ããããããšæã£ãŠãããã©ãïŒåæããªããšãããªææãäžãããªããããªã®ã§ãããå°ãææ
¢ããŸãã
暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ
ã§ããæäœãäœå
ã«äœãããŠãããšããç 究çµæããŸãšããŸããã
ã¯ã¯ãã³ã2åæ¥çš®ãããš9å²ä»¥äžã®ç¢ºçã§å€ç°æ ªã«ãå¹æããããšããã NHKãã¥ãŒã¹
ã暪æµåžç«å€§åŠã
ãæ°åã³ããå€ç°æ ªã«å¯Ÿããã¯ã¯ãã³æ¥çš®è ã®9å²ããæµè¡å€ç°æ ªã«å¯Ÿããäžåæäœãä¿æããããšãæããã«ã
1/2
ãæ°åã³ããå€ç°æ ªã«å¯Ÿããã¯ã¯ãã³æ¥çš®è ã®9å²ããæµè¡å€ç°æ ªã«å¯Ÿããäžåæäœãä¿æããããšãæããã«ã
1/2
ã ã« ã¯å¹ãã®ïŒ
ã¯ã¯ãã³ïŒãã¡ã€ã¶ãŒè£œïŒãå€ç°ãŠã€ã«ã¹ã«2åæ¥çš®ã§å¹æãè¡šããã®ã
ïŒ
暪åžã®å®éšã以åã®æµ·å€ã®ããŒã¿ããã1åã®æ¥çš®ã§ã®æ°å€ãã¡ãã£ãšäœã?âŠæµ·å€ããŒã¿ã¯"åŸæ¥æ ª"ãšããäºïŒã§ã"åŸæ¥æ ª"ã£ãŠæŠæŒ¢ïŒæ¬§å·æ ªãã掟çããæ¥æ¬ã®æ ªïŒïŒæ°åã2å²ãããã5å²ãããã®ããã«å€§éæã«èŠãæ¹ãããããïŒ
暪åžã®å®éšã以åã®æµ·å€ã®ããŒã¿ããã1åã®æ¥çš®ã§ã®æ°å€ãã¡ãã£ãšäœã?âŠæµ·å€ããŒã¿ã¯"åŸæ¥æ ª"ãšããäºïŒã§ã"åŸæ¥æ ª"ã£ãŠæŠæŒ¢ïŒæ¬§å·æ ªãã掟çããæ¥æ¬ã®æ ªïŒïŒæ°åã2å²ãããã5å²ãããã®ããã«å€§éæã«èŠãæ¹ãããããïŒ
ïŒ âŒ å»ç
暪æµåžå€§ïŒ
暪æµåžå€§ïŒ
ããŒããã£ããã£ãã
ãã®ãã¥ãŒã¹ã§ãããä¿¡é Œæ§ãããªãé«ãããªæãã§ãã
ãã®ãã¥ãŒã¹ã§ãããä¿¡é Œæ§ãããªãé«ãããªæãã§ãã
äžåæäœâ2åæ¥çš®ã§åããŠå¹æãããã£ãŠããšãã
å
æ¥è±èªã®ãã¡ã€ã¶ãŒHPãæãããã©ã第äžè
æ©é¢ã«ãã£ãŠããä»ã®ãšããæ¥æ¬ã§ç¢ºèªãããŠããå€ç°ãŠã€ã«ã¹ã«ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ãæå¹ã§ããããšã確èªãããŸããã
âå
è¡æ¥çš®åœã§å¹æãå®èšŒãããŠãã
æ»ã«ãããªããã°åã®äºã®èšããæ¥çš®ã
ææåŸã«åŸæãã¬æ§ã«
æ»ã«ãããªããã°åã®äºã®èšããæ¥çš®ã
ææåŸã«åŸæãã¬æ§ã«
åŸæ¥æ ªããæŠæŒ¢æ ªããäžåœæ ªããšèšããªãæ¥æ¬ã®ã¡ãã£ã¢
å¹ãïŒ
ã¯ã¯ãã³ãã€æãŠãã®ãããå€ç°æ ªã«ãçµæ§ããããœããããã飜ããã®ãçµãããããã
次㯠(å
¥åœèŠå¶ä»æŽé
ãæ¢ã«å
¥ã£ãŠãŸã)
ã«å¯ŸããåŸæ¥åã¯ã¯ãã³å¹æãæ°ã«ãªã£ãŠãç§ã§ãã
暪æµåžç«å€§åŠå»åŠéšå±±äžææãªãã³ã«ç 究ããŒã æ§ã«æè¬ãå çšÑvåºæŒããä»°ãããŠãŸãããã¡ãã£ã¢ã¯äžå®ãç œãããããããã£ãåãããªåžæãããŠãæ å ±ãâŠã
ã«å¯ŸããåŸæ¥åã¯ã¯ãã³å¹æãæ°ã«ãªã£ãŠãç§ã§ãã
暪æµåžç«å€§åŠå»åŠéšå±±äžææãªãã³ã«ç 究ããŒã æ§ã«æè¬ãå çšÑvåºæŒããä»°ãããŠãŸãããã¡ãã£ã¢ã¯äžå®ãç œãããããããã£ãåãããªåžæãããŠãæ å ±ãâŠã
ïŒåæ¥çš®ããŸãå¿
èŠã¿ããð€
äžäœèªåã¯æã€ã¹ããïŒæ©ãâŠ
ã§ãæããªããšæ¥åžžã®æŽ»åç¯å²ã§
å¶éåºãã®ããªïŒã¯ã¯ãã³ãã¹ããŒããå¿ èŠã«ãªã£ãŠãããšâŠã
ãŒãŒãŒãŒ
äžäœèªåã¯æã€ã¹ããïŒæ©ãâŠ
ã§ãæããªããšæ¥åžžã®æŽ»åç¯å²ã§
å¶éåºãã®ããªïŒã¯ã¯ãã³ãã¹ããŒããå¿ èŠã«ãªã£ãŠãããšâŠã
ãŒãŒãŒãŒ
NHKããããªå ±éããŠãŸããã³ããçŠã®æ ¹æºã誀èªãããæ°ãèŠãèŠãã§ã
ïŒããäžåœç±æ¥ãæããããªãã§ä»åœã«ãªããã€ããå°è±¡æäœã®äžç°ã§ãããã
ïŒããäžåœç±æ¥ãæããããªãã§ä»åœã«ãªããã€ããå°è±¡æäœã®äžç°ã§ãããã
ãããããåŸæ¥æ ªãã£ãŠæµç³æ¥æ¬ã®å
Œ
±æŸéã§ã¯ãªãNHKã ããã
ãäžåœæ ªïŒãªãªãžãã«ïŒãããæŠæŒ¢æ ªïŒãªãªãžãã«ïŒãäœæžããªããšãŸãã§å°åæžãããä»ã®å Žæãçºçæºãšèª€èªãããããªãã
ãäžåœæ ªïŒãªãªãžãã«ïŒãããæŠæŒ¢æ ªïŒãªãªãžãã«ïŒãäœæžããªããšãŸãã§å°åæžãããä»ã®å Žæãçºçæºãšèª€èªãããããªãã
ä¿¡çšããŠããã®ãïŒã¹ã¿ããã¹ããããªãããš
ãã ã®åŠæ³ã®çµæã§ãã
æ°åã³ããã®å€ç°ãŠã€ã«ã¹ðŠ ã¯ãã¯ã¯ãã³2åæ¥çš®ã§å¹æãããïŒæäœãã§ããïŒããšãåãã£ãŠãããã§ããð
ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»
ð³ ãªãã±åç» ð³
ããŽãŒã€ãã£ã³ãã«ãŒïŒïŒã
ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»ã»
ð³ ãªãã±åç» ð³
ããŽãŒã€ãã£ã³ãã«ãŒïŒïŒã
æ¥æ¬ã§ã®100人ã«å¯Ÿãã調æ»ã
ä»æ¥æ¬ã§ã¯ãã¡ã€ã¶ãŒç€Ÿè£œã®ã¯ã¯ãã³ã䜿ãããŠããããã§ãããïŒåæ¥çš®åŸã«ã¯ãã£ãããšå€ç°çš®ã«ãå¹ãããã§ããã£ãã§ãã(*'âœ'*)ïŒ
ã§ãïŒåç®ãã£ãŠãå¹æãåºããŸã§æéãããã(ïŒé±é)ã®ã§æ³šæïŒ
ä»æ¥æ¬ã§ã¯ãã¡ã€ã¶ãŒç€Ÿè£œã®ã¯ã¯ãã³ã䜿ãããŠããããã§ãããïŒåæ¥çš®åŸã«ã¯ãã£ãããšå€ç°çš®ã«ãå¹ãããã§ããã£ãã§ãã(*'âœ'*)ïŒ
ã§ãïŒåç®ãã£ãŠãå¹æãåºããŸã§æéãããã(ïŒé±é)ã®ã§æ³šæïŒ
2åæã£ãŠæäœãã§ããã°å®å
šäœã«ãªããŸã(ç¬)
ãã¯ãã2åæ¥çš®ãæå¹ã¿ããã§ããã
ã¯ã¯ãã³ã¯äžæçã«ã¯å¹ãã ããããçµå±ã¯æ¯å¹Žã®ããã«æã€ããšã«ãªããã¹ãã€ã¯ã«å¯Ÿããäžåæäœã®æç¶ã¯å幎ã»ã©ããã®éã«ã³ãããå°ã蟌ããããããšã¯ãªãããå¿
ãå€ç°ãããå¿
èŠãªã®ã¯ãã€ã³ããå€ããããšãã¯ã¯ãã³ã¯äžèœã§ãªããã
ãã¯ãã¯ã¯ãã³ã¯äºåæ¥çš®å¿
èŠãšããäºã§ãããâŠ
ããã¯æå ±ã
æ¢åã³ããã99%ã
ã€ã®ãªã¹å94%ã
ã€ã³ãåã97%ã«äžåæäœåå¿ã
ã¯ã¯ãã³ã¯ããã¯ãã
æ¢åã³ããã99%ã
ã€ã®ãªã¹å94%ã
ã€ã³ãåã97%ã«äžåæäœåå¿ã
ã¯ã¯ãã³ã¯ããã¯ãã
èšåºç 究ã§ã¯ãªã(ææ³â )ã®ãšãµã³ãã«ãå°ãªãã®ã§ãã©ããªãã ãïŒå€ç°æ ªã«ãããããå¹ããªããããããã¥ãŒã¹ã ãã©
# 暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ
ã§ããæäœãäœå
ã«äœãããŠãããšããç 究çµæããŸãšããŸããã
NHKãã¥ãŒã¹
NHKãã¥ãŒã¹
mRNAã¯ã¯ãã³ã®é²åŸ¡å¹æã¯æäœã®ã¿ã§ã¯ãªãã现èæ§å
ç«ã§è³Šäžãããéšåãããã®ã§ããã¯ãå¹æã¯ååæåŸ
ã§ãããšæãããŸãã
éçåé»æ¢å¹æãªããæ°åã¯ããå°ãäžä¹ããããã®ãããããŸããã
éçåé»æ¢å¹æãªããæ°åã¯ããå°ãäžä¹ããããã®ãããããŸããã
ãå
šäœã®89ïŒ
ã®äººã¯ã€ã®ãªã¹ãåã¢ããªã«ãããã«ãã©ãžã«ãªã©ã§åãããŠåãããŠ7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ
ã§ããéã®äžåæäœããäœå
ã«äœãããŠããããã®çµæã¯åžæã®ããŠãç 究ã
1åæ¥çš®ãš2åæ¥çš®ã®å·®ãããã
ãã¡ã€ã¶ãŒ2åæ¥çš®åŒ·ã£
èšäºã®çµè«çãèŠãæãå人差ã¯ãããã©ã»ãŒå€§äžå€«ã£ãŠäºãã
1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«
ããã«äžç©...
ãšããã€ã€ãç±³åœæ ªä¿ææ¯çã¯å€ããŸãããã
ãšããã€ã€ãç±³åœæ ªä¿ææ¯çã¯å€ããŸãããã
暪æµåžç«å€§åŠç 究
ã¯ã¯ãã³2åæ¥çš®105人åæ
çŽ9å²ã¯å€ç°æ ªã«å¯ŸããŠå¹ææåŸ ã§ããæäœçæ
1åç®ã§ã¯
è±åœæ ª18%ð
åã¢æ ª21%
ãã©ãžã«æ ª16%
ã€ã³ãæ ª37%ð
ã«ãªãã©ã«ãã¢æ ª39%
ãã¥ãŒãšãŒã¯æ ª55%
åŸæ¥æ ª57%
ã€ã³ãæ ªã«ãçµæ§å¹ãããð
ã¯ã¯ãã³2åæ¥çš®105人åæ
çŽ9å²ã¯å€ç°æ ªã«å¯ŸããŠå¹ææåŸ ã§ããæäœçæ
1åç®ã§ã¯
è±åœæ ª18%ð
åã¢æ ª21%
ãã©ãžã«æ ª16%
ã€ã³ãæ ª37%ð
ã«ãªãã©ã«ãã¢æ ª39%
ãã¥ãŒãšãŒã¯æ ª55%
åŸæ¥æ ª57%
ã€ã³ãæ ªã«ãçµæ§å¹ãããð
ããã¯æå ±ã ððâ
NHKãã€ã®ãªã¹ã åã¢ããªã«ã å€ç°æ ªèšã£ãŠããã©ãŸãã¯åŸæ¥æ ªã¯äžåœãŠã€ã«ã¹ã£ãŠèšãã¹ããããªãã®ã
YCU調ã¹ã
å®é調æ»ã§ã¯ãªãã®ã§å€ç°æ ªéã§ã®äžåå䟡ã®äœäžã®è©äŸ¡ãé£ããããæäœã¯ç²åŸããã
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
å®é調æ»ã§ã¯ãªãã®ã§å€ç°æ ªéã§ã®äžåå䟡ã®äœäžã®è©äŸ¡ãé£ããããæäœã¯ç²åŸããã
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
ããã¯è¯ããã¥ãŒã¹ããã©å€ç°æ ªã«ã¯2åæ¥çš®ãå¿
ãå¿
èŠãšããããšãæ確ã«ãªã£ãã
ãããŠããâš
çŽ æŽããããããªããâš
çŽ æŽããããããªããâš
ããã¯è¯ããã¥ãŒã¹ã
ïŒåã ãšå¹ãç®ã¯ã€ãã€ãã¿ãããªã®ã§ãé«éœ¢è ãšé«éœ¢è æœèšã®é¢ä¿è ã«æ©ãïŒåæã€å¿ èŠãããããã§ããã
ïŒåã ãšå¹ãç®ã¯ã€ãã€ãã¿ãããªã®ã§ãé«éœ¢è ãšé«éœ¢è æœèšã®é¢ä¿è ã«æ©ãïŒåæã€å¿ èŠãããããã§ããã
Ί(.. )
å ç«åŠïŒmRNAã¯ã¯ãã³ã®æå¹æ§ã¯äžéšã®SARS-CoV-2å€ç°æ ªã«å¯ŸããŠãããã«äœããªã£ãŠãã | Nature | Nature Portfolio:
å ç«åŠïŒmRNAã¯ã¯ãã³ã®æå¹æ§ã¯äžéšã®SARS-CoV-2å€ç°æ ªã«å¯ŸããŠãããã«äœããªã£ãŠãã | Nature | Nature Portfolio:
ã»ïŒåç®ã®æ¥çš®åŸ
âå®å¿ããŠïœ³ïœªïœ°ïœ²â
ã»ïŒåç®ã®æ¥çš®çŽåŸ
âååã®ïœ³ïœªïœ°ïœ²â
ã»ïŒåç®æ¥çš®ã®çŽäºé±éçµéåŸ
âççºã®ïœ³ïœªïœ°ïœ²âã身è¿ãªäººããå°ããã€ïœ³ïœªïœ°ïœ²ð¥ããªã
âå®å¿ããŠïœ³ïœªïœ°ïœ²â
ã»ïŒåç®ã®æ¥çš®çŽåŸ
âååã®ïœ³ïœªïœ°ïœ²â
ã»ïŒåç®æ¥çš®ã®çŽäºé±éçµéåŸ
âççºã®ïœ³ïœªïœ°ïœ²âã身è¿ãªäººããå°ããã€ïœ³ïœªïœ°ïœ²ð¥ããªã
ã¯ã¯ãã³ã«æåŸ
ïŒ
å
šäœã®89ïŒ
ã®äººã¯ã€ã®ãªã¹ãåã¢ããªã«ããã©ãžã«ãªã©ã§åãããŠ7ã€ã®å€ç°ãŠã€ã«ã¹ãã¹ãŠã«ã€ããŠãå¹æãæåŸ
ã§ããéã®äžåæäœããäœå
ã«äœãããŠããããšãããã£ãã
â1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«â
âãã ãå šå¡ã«äžåæäœãã§ããããã§ã¯ãªããå人差ããããä»åŸããã«å¯Ÿè±¡è ãåºããŠããŒã¿ãèç©ããŠããããããšè©±ããŠããŸããâ
âãã ãå šå¡ã«äžåæäœãã§ããããã§ã¯ãªããå人差ããããä»åŸããã«å¯Ÿè±¡è ãåºããŠããŒã¿ãèç©ããŠããããããšè©±ããŠããŸããâ
æã£ãããããšããããã®äžåããå¹ãç®è¶³ããã®ã
æ©ã2åæã¡ãããª
æ©ã2åæã¡ãããª
æ¥æ¬äººã®ããŒã¿ã ããä¿¡ææ§ããããªã
ãããä»ã§ãã¯ã¯ãã³ã«æççãªå±€ããã ããããèšãæ¹ãªãã ãããã©ããããŸã§âä»ãæ¥æ¬ã§æ¥çš®ãããŠããã¯ã¯ãã³âããšãã¡ã€ã¶ãŒè£œã®ã¯ã¯ãã³ã®è©±ã ãšããã®ã¯ãã¡ããš(ãã¬ãã®ãã¥ãŒã¹ã§ã)èšã£ãŠã»ããã
___
___
ã暪æµåžç«å€§åŠã®ç 究ã°ã«ãŒããã¯ã¯ãã³ã2åæ¥çš®ãã100人äœãã«ã€ããŠåæãããšãããããã9å²ã®äººã¯å€ç°æ ªã«å¯ŸããŠå¹æãæåŸ
ã§ããæäœãäœå
ã«äœãããŠããã
äžéšã®å ±éãèšãã»ã©ã€ã³ãå€ç°æ ªã¯æ·±å»ã§ã¯ãªã
äžéšã®å ±éãèšãã»ã©ã€ã³ãå€ç°æ ªã¯æ·±å»ã§ã¯ãªã
ã¯ã¯ãã³æã£ãŠãèªç±ã¯ç¡ããã©
å¹æãããŒã¿ã«åºãã®ã¯ä¹ ãã¶ãã«è¯ããã¥ãŒã¹ð
1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«
å¹æãããŒã¿ã«åºãã®ã¯ä¹ ãã¶ãã«è¯ããã¥ãŒã¹ð
1åç®2å²æªæºã®å€ç°æ ªãâ2åæ¥çš®ã§9å²ä»¥äžã®å¹æã«
ïŒ
ð 
ð 
NHK5/12ïŒ â
æ¯æ°å°ãªããèšåºçµæããã1åç®å¹æã¯åŸæ¥æ ªã§åæ°è¶
ãã»å€ç°æ ªã¯åæ°ä»¥äžã2åç®å¹æã¯å€ç°æ ªã9å²å°ã§æäœãåºæ¥ããã€ãŸã1åã§ã¯æ²¹æçŠç©ã2åæã£ãŠã1å²åŒ±ã¯å¹æãã·ãæã€æããªãã®åèææšã«ãã
ã€ã£ã - "
ã€ã³ãæ ªã®æ¹ãè±åœåãããåŸæ¥åã«è¿ãå¯èœæ§ããããã€ã³ãæ ªãæµå
¥ããŠã倧ããªæ³¢ã«ãªããªããšèšããã
極床ã«æããå¿ èŠãªãã
極床ã«æããå¿ èŠãªãã
å€ç°ã«ãå¹æãæåŸ
ã§ããããšã®ããšãªã®ã§ã2åç®æ¥çš®åŸã«38.9âãŸã§çºç±åºãŠããã©ãæããããããã©ãæ¥çš®ããŠããã£ããšæããâ
âäžæ¹ã§ã1åç®ã®æ¥çš®åŸã§ã¯ãã€ã®ãªã¹æ ªã¯18ïŒ
ãåã¢ããªã«æ ªã¯21ïŒ
ããã©ãžã«æ ªã¯16ïŒ
ãã€ã³ãæ ªã¯37ïŒ
ãã«ãªãã©ã«ãã¢æ ªã¯39ïŒ
ããã¥ãŒãšãŒã¯æ ªã¯55ïŒ
ãç±æ¥äžææ ªã¯34ïŒ
ã®äººã«ãšã©ãŸã£ããšããããšã§ããâ
2åç®ãæããªããšãããªã«ã¯å¹ããªããã ãªãã
æ¯ã¯ãã¡ã€ã¶ãŒè£œãæ¥çš®äºå®ã ãããå®å¿ã§ããã
ã³ããæ»è
ã¯ã»ãŒé«éœ¢è
ãªã®ã§7ææ«ã«é«éœ¢è
ã®æåãçµãã£ããå®è³ªã³ããçŠçµäºã
"ã¯ã¯ãã³ã¯2åæ¥çš®ããã°çŸåšåºãŠããŠããå€ç°ãŠã€ã«ã¹ã«å¯ŸããŠãäžåæäœã«ããå
ç«ãæåŸ
ã§ããçµæãšãªã£ãã"
ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³2åæ¥çš®ã§å€ç°æ ªã«90%以äžæå¹
ããã¯æå ±ð
ããããã
å㞠次ãž